#194: CoQ10 supplementation; Mediterranean diet slows atherosclerosis; new mineralocorticoid-receptor antagonist; sparks fly at FDA over ARB-cancer controversy: WSJ

Summary: For the week ending June 7, 2013 we discuss the following top cardiology news from heartwire: Coenzyme Q10 supplementation reduces HF admissions and improves survival: Q-SYMBIO Mediterranean diet slows atherosclerosis progression in PREDIMED New mineralocorticoid-receptor antagonist passes in phase 2 study Sparks fly within FDA over longstanding ARB-cancer controversy: WSJ And also, in brief: NSAID CV-event risk high overall, but predictable in individuals, says analysis Four healthy lifestyle behaviors lower risk of death, slow CAC progression Join us for a comprehensive review of this week's most important cardiology news.